NO973193D0 - Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer - Google Patents

Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer

Info

Publication number
NO973193D0
NO973193D0 NO973193A NO973193A NO973193D0 NO 973193 D0 NO973193 D0 NO 973193D0 NO 973193 A NO973193 A NO 973193A NO 973193 A NO973193 A NO 973193A NO 973193 D0 NO973193 D0 NO 973193D0
Authority
NO
Norway
Prior art keywords
collagen
formulations
treatment
immune system
based methods
Prior art date
Application number
NO973193A
Other languages
English (en)
Other versions
NO973193L (no
Inventor
Thomas B Neff
George R Martin
Karl A Piez
Taina A Pihlajaniemi
Kari Ilkka Kivirikko
Original Assignee
Fibrogen Inc
Academy Of Finland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc, Academy Of Finland filed Critical Fibrogen Inc
Publication of NO973193D0 publication Critical patent/NO973193D0/no
Publication of NO973193L publication Critical patent/NO973193L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO973193A 1995-01-10 1997-07-09 Kollagen-baserte fremgangsmåter og formuleringer for behandling av immunsystemformidlede sykdommer NO973193L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37038895A 1995-01-10 1995-01-10
PCT/US1996/000533 WO1996021458A1 (en) 1995-01-10 1996-01-11 Collagen-based methods and formulations for the treatment of immune system-mediated diseases

Publications (2)

Publication Number Publication Date
NO973193D0 true NO973193D0 (no) 1997-07-09
NO973193L NO973193L (no) 1997-09-09

Family

ID=23459429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973193A NO973193L (no) 1995-01-10 1997-07-09 Kollagen-baserte fremgangsmåter og formuleringer for behandling av immunsystemformidlede sykdommer

Country Status (10)

Country Link
EP (1) EP0805686A1 (no)
JP (1) JPH10512554A (no)
AU (1) AU4657096A (no)
BR (1) BR9606753A (no)
CA (1) CA2210088A1 (no)
FI (1) FI972929A7 (no)
HU (1) HUP9800829A3 (no)
MX (1) MX9705198A (no)
NO (1) NO973193L (no)
WO (1) WO1996021458A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
EP0886471A4 (en) * 1996-11-18 2002-07-17 Emisphere Tech Inc METHODS AND COMPOSITIONS FOR INDUCING ORAL TOLERANCE IN MUZZLES
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
DE19804210A1 (de) 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Rekombinante Mistellektine
CA2339575A1 (en) * 1998-08-10 2000-02-24 James W. Polarek Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
KR102577697B1 (ko) * 2019-11-13 2023-09-14 주식회사 나이벡 염증 및 상처 치료용 펩타이드
WO2021118379A1 (en) * 2019-12-12 2021-06-17 Ineb - Instituto De Engenharia Biomédica Fetal decellularized nucleus pulposus material and methods for obtaining pharmaceutic compositions to be used in the treatment of intervertebral disc degeneration and back pain
DE102021202830A1 (de) * 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
DE102021214899A1 (de) * 2021-12-22 2023-06-22 Gelita Ag Typ I-Kollagenpeptid zur therapeutischen Verwendung
JP7357189B1 (ja) * 2022-07-14 2023-10-06 株式会社リナイス 魚類軟骨由来のコラーゲン含有組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
HUP9800829A3 (en) 1999-09-28
WO1996021458A1 (en) 1996-07-18
FI972929A0 (fi) 1997-07-10
CA2210088A1 (en) 1996-07-18
MX9705198A (es) 1997-12-31
BR9606753A (pt) 1998-01-06
FI972929A7 (fi) 1997-09-10
EP0805686A1 (en) 1997-11-12
JPH10512554A (ja) 1998-12-02
HUP9800829A2 (hu) 1998-07-28
NO973193L (no) 1997-09-09
AU4657096A (en) 1996-07-31

Similar Documents

Publication Publication Date Title
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
EP0907369A4 (en) MATERIALS AND METHODS FOR TREATING MULTIPLE DISEASES
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO923875D0 (no) Metode og preparat for behandling av trombose
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
NO992641D0 (no) Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
FI964874A0 (fi) Vihannesten käsittely
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO974965L (no) Fremgangsmåter og formuleringer for modulering av den humane seksualrespons
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
NO893240D0 (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
NO971900D0 (no) Blandinger og behandling av multippel sklerose
NO932915D0 (no) Mikroporoest krystallinsk silikoaluminofosfat og fremgangsmaate for fremstilling av dette
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
NO973980D0 (no) Imiadazolderivater og medisinsk preparat
NO932912D0 (no) Preparat og fremgangsmaater til generering av ben
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
NO953002D0 (no) Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater